Phathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 7c
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Join SI Premium – FREE
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q2 EPS of ($1.25), $0.07 better than the analyst estimate of ($1.32). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $5.68 million.
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- Transact Technologies (TACT) Tops Q2 EPS by 1c
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
